{"id":32682,"date":"2024-08-28T14:41:00","date_gmt":"2024-08-28T14:41:00","guid":{"rendered":"https:\/\/beyondtype2.org\/resources\/fda-omnipod-5-diabetes-tipo-2\/"},"modified":"2024-08-28T14:41:00","modified_gmt":"2024-08-28T14:41:00","slug":"fda-omnipod-5-diabetes-tipo-2","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/","title":{"rendered":"La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2"},"content":{"rendered":"<p><a href=\"https:\/\/www.insulet.com\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Insulet Corporation<\/span><\/a><span style=\"font-weight: 400;\"> ha recibido la aprobaci&oacute;n de la FDA (Administraci&oacute;n de Alimentos y Medicamentos de los Estados Unidos) para ampliar el uso de su sistema automatizado de administraci&oacute;n de insulina <\/span><a href=\"https:\/\/beyondtype1.org\/omnipod-5-fda-approved\/?__hstc=215771272.ad4efbb375d7076be1a7866ef74d2d1e.1721252604737.1724197759681.1724782807354.5&amp;__hssc=215771272.1.1724782807354&amp;__hsfp=737864036\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Omnipod 5<\/span><\/a><span style=\"font-weight: 400;\"> para que incluya a los adultos con <\/span><a href=\"https:\/\/beyondtype1.org\/es\/que-es-la-diabetes-tipo-2\/\"><span style=\"font-weight: 400;\">diabetes tipo 2<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Esta nueva autorizaci&oacute;n marca un hito importante para la empresa con sede en Acton, Massachusetts y ampl&iacute;a su base de clientes potenciales.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La aprobaci&oacute;n se produce tras un estudio reciente que demuestra que el Omnipod 5 mejora significativamente el manejo de la glucosa en sangre en personas con diabetes tipo 2. Los hallazgos clave del estudio incluyen:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">reducciones en los <\/span><a href=\"https:\/\/beyondtype1.org\/es\/comprendiendo-el-a1c\/\"><span style=\"font-weight: 400;\">niveles de A1c<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">menos tiempo con <\/span><a href=\"https:\/\/beyondtype1.org\/es\/hiperglucemia-y-como-tratarla\/\"><span style=\"font-weight: 400;\">hiperglucemia<\/span><\/a><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">una menor necesidad diaria de <\/span><a href=\"https:\/\/beyondtype1.org\/es\/nuevo-insulina-basal\/\"><span style=\"font-weight: 400;\">insulina<\/span><\/a><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Todo ello manteniendo niveles seguros de glucosa en sangre y reduciendo el estr&eacute;s relacionado con la diabetes.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Actualmente, m&aacute;s de 30 millones de personas en los EE. UU. tienen diabetes tipo 2 y aproximadamente 6 millones requieren terapia con insulina.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">De ellos, alrededor de 2,5 millones manejan su enfermedad con inyecciones diarias m&uacute;ltiples.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Insulet tiene como objetivo ofrecer a estas personas una alternativa m&aacute;s c&oacute;moda y eficaz con el sistema Omnipod 5.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>https:\/\/beyondtype1.org\/es\/wp-content\/uploads\/2024\/05\/DAN-1.png<\/p>\n<p>Dan ha escrito sobre diabetes durante m&aacute;s de 20 a&ntilde;os. Fue uno de los primeros reclutas de Diabetes Health y, a lo largo de sus m&aacute;s de 10 a&ntilde;os como editor en jefe, escribi&oacute; y public&oacute; miles de art&iacute;culos y ayud&oacute; a establecer a Diabetes Health como el principal recurso para personas con diabetes. M&aacute;s adelante se convirti&oacute; en director de contenido de OneTouchGold, la publicaci&oacute;n digital oficial de Johnson &amp; Johnson\/LifeScan para sus clientes de tecnolog&iacute;a de medici&oacute;n. Bajo su liderazgo, OneTouchGold recibi&oacute; el premio de la Web Marketing Association al &ldquo;Mejor sitio web de salud y bienestar&rdquo;. Dan tambi&eacute;n ha escrito para Diabetes Research Institute, dLife, diaTribe, Healthline, CareDx, Pendulum Therapeutics y Hero Bread.<\/p>\n<p>LatestHome<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Insulet Corporation ha recibido la aprobaci&oacute;n de la FDA (Administraci&oacute;n de Alimentos y Medicamentos de los Estados Unidos) para ampliar el uso de su sistema automatizado de administraci&oacute;n de insulina Omnipod 5 para que incluya a los adultos con diabetes tipo 2. Esta nueva autorizaci&oacute;n marca un hito importante para la empresa con sede en [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":32684,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-32682","resources","type-resources","status-publish","has-post-thumbnail","hentry","diabetes-types-tipo-2","tags-latesthome"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2 | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"El sistema automatizado de administraci\u00f3n de insulina Omnipod 5 de Insulet recibe la aprobaci\u00f3n de la FDA para adultos con diabetes tipo 2, lo que ampl\u00eda su alcance en el mercado.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2 | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"El sistema automatizado de administraci\u00f3n de insulina Omnipod 5 de Insulet recibe la aprobaci\u00f3n de la FDA para adultos con diabetes tipo 2, lo que ampl\u00eda su alcance en el mercado.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-OMNIPOD-5-HEADER-1980x709-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1980\" \/>\n\t<meta property=\"og:image:height\" content=\"709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/\",\"name\":\"La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2 | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-OMNIPOD-5-HEADER-1980x709-1.png\",\"datePublished\":\"2024-08-28T14:41:00+00:00\",\"description\":\"El sistema automatizado de administraci\u00f3n de insulina Omnipod 5 de Insulet recibe la aprobaci\u00f3n de la FDA para adultos con diabetes tipo 2, lo que ampl\u00eda su alcance en el mercado.\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-OMNIPOD-5-HEADER-1980x709-1.png\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-OMNIPOD-5-HEADER-1980x709-1.png\",\"width\":1980,\"height\":709},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2 | Beyond Type 1","description":"El sistema automatizado de administraci\u00f3n de insulina Omnipod 5 de Insulet recibe la aprobaci\u00f3n de la FDA para adultos con diabetes tipo 2, lo que ampl\u00eda su alcance en el mercado.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/","og_locale":"es_ES","og_type":"article","og_title":"La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2 | Beyond Type 1","og_description":"El sistema automatizado de administraci\u00f3n de insulina Omnipod 5 de Insulet recibe la aprobaci\u00f3n de la FDA para adultos con diabetes tipo 2, lo que ampl\u00eda su alcance en el mercado.","og_url":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","og_image":[{"width":1980,"height":709,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-OMNIPOD-5-HEADER-1980x709-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/","url":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/","name":"La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2 | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-OMNIPOD-5-HEADER-1980x709-1.png","datePublished":"2024-08-28T14:41:00+00:00","description":"El sistema automatizado de administraci\u00f3n de insulina Omnipod 5 de Insulet recibe la aprobaci\u00f3n de la FDA para adultos con diabetes tipo 2, lo que ampl\u00eda su alcance en el mercado.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-OMNIPOD-5-HEADER-1980x709-1.png","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-OMNIPOD-5-HEADER-1980x709-1.png","width":1980,"height":709},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/fda-omnipod-5-diabetes-tipo-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"La FDA aprueba Omnipod 5 de Insulet para las personas con diabetes tipo 2"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/32682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=32682"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/32682\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/32684"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=32682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}